Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa

Thromb Haemost. 1999 Aug;82(2):531-9.

Author

U Hedner¹

Affiliation

¹ Department of Coagulation Disorders, University Hospital of Malmö, University of Lund, Sweden.

PMID: 10605747

No abstract available

Publication types

Review

MeSH terms

Anaphylaxis
Animals
Antibodies
Factor IX / immunology
Factor IX / therapeutic use*
Factor VIII / immunology
Factor VIII / therapeutic use*
Factor VIIa / immunology
Factor VIIa / pharmacology
Factor VIIa / therapeutic use*
Hemophilia A / drug therapy*
Hemophilia A / immunology
Hemophilia B / drug therapy*
Hemophilia B / immunology
Humans
Immune Tolerance
Immunosuppression Therapy
Recombinant Proteins / therapeutic use

Substances

Antibodies
Recombinant Proteins
Factor VIII
Factor IX
Factor VIIa